MX2013001447A - Metodo de produccion y purificacion de una sialiltransferasa soluble activa. - Google Patents

Metodo de produccion y purificacion de una sialiltransferasa soluble activa.

Info

Publication number
MX2013001447A
MX2013001447A MX2013001447A MX2013001447A MX2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A MX 2013001447 A MX2013001447 A MX 2013001447A
Authority
MX
Mexico
Prior art keywords
sialyltransferase
polypeptide
purifying
producing
active soluble
Prior art date
Application number
MX2013001447A
Other languages
English (en)
Spanish (es)
Inventor
Axel Angermann
Christian Scheckermann
Karsten Schmidt
Original Assignee
Biogenerix Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogenerix Gmbh filed Critical Biogenerix Gmbh
Publication of MX2013001447A publication Critical patent/MX2013001447A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1081Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/99Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
    • C12Y204/99003Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase (2.4.99.3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
MX2013001447A 2010-08-02 2011-08-02 Metodo de produccion y purificacion de una sialiltransferasa soluble activa. MX2013001447A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20100171626 EP2415779B1 (en) 2010-08-02 2010-08-02 Method of producing and purifying an active soluble sialyltransferase
PCT/EP2011/063291 WO2012016984A1 (en) 2010-08-02 2011-08-02 Method of producing and purifying an active soluble sialyltransferase

Publications (1)

Publication Number Publication Date
MX2013001447A true MX2013001447A (es) 2013-11-20

Family

ID=42736163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013001447A MX2013001447A (es) 2010-08-02 2011-08-02 Metodo de produccion y purificacion de una sialiltransferasa soluble activa.

Country Status (9)

Country Link
US (1) US9222081B2 (enExample)
EP (2) EP2415779B1 (enExample)
JP (1) JP5984267B2 (enExample)
CN (1) CN103154017B (enExample)
CA (1) CA2807397C (enExample)
ES (1) ES2534936T3 (enExample)
MX (1) MX2013001447A (enExample)
PT (1) PT2415779E (enExample)
WO (1) WO2012016984A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
JP2016513245A (ja) * 2013-02-06 2016-05-12 エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ タンパク質製剤の凝集体含有量を減少させる混合多官能金属親和性表面
HUE038741T2 (hu) 2013-05-06 2018-11-28 Sanofi Sa Folyamatos többlépéses eljárás antitestek tisztítására
KR20170132293A (ko) * 2015-03-31 2017-12-01 예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 글루타메이트 옥살로아세테이트 트랜스아미나제 1(got1) 제제와 이의 제조방법 및 용도
KR101667677B1 (ko) * 2015-05-29 2016-10-19 한국생명공학연구원 재조합 ST6Gal1 단백질을 활성형으로 제조하는 방법
EP3559250A1 (en) 2016-12-21 2019-10-30 H. Hoffnabb-La Roche Ag Re-use of enzymes in in vitro glycoengineering of antibodies
AU2017381657B2 (en) 2016-12-21 2020-07-23 F. Hoffmann-La Roche Ag Method for in vitro glycoengineering of antibodies
EP3678687B1 (en) 2017-09-04 2022-08-17 89Bio Ltd. Mutant fgf-21 peptide conjugates and uses thereof
WO2019063849A1 (en) * 2017-12-20 2019-04-04 Dsm Ip Assets B.V. PURIFICATION OF A POLYPEPTIDE OF INTEREST
EP3546475A1 (en) 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
KR102362777B1 (ko) * 2018-03-27 2022-02-15 주식회사 녹십자 친화성 크로마토그래피 공정을 포함하는 백일해균 유래 단백질 수득 방법
KR102140531B1 (ko) * 2018-08-07 2020-08-04 (주)휴온스 Gly-Tβ4의 제조방법
EP3613486B1 (de) * 2018-08-24 2020-10-07 UGA Biopharma GmbH Verfahren und anlage zur reinigung von epo und/oder einem epo-derivat
CN113416243B (zh) * 2021-08-23 2021-12-10 上海盛迪医药有限公司 一种纯化抗体的方法
CN119912505A (zh) * 2025-04-02 2025-05-02 浙江熙正霖生物科技有限公司 一种从发酵液中提纯唾液酸的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5032519A (en) * 1989-10-24 1991-07-16 The Regents Of The Univ. Of California Method for producing secretable glycosyltransferases and other Golgi processing enzymes
EP0737745A4 (en) 1993-12-24 1999-06-16 Rikagaku Kenkyusho INNOVATIVE SYNTHETASE FOR SUGAR CHAINS AND METHOD FOR THEIR PRODUCTION
US6280989B1 (en) * 1999-06-17 2001-08-28 Dmitri Kapitonov Sialyltransferases
ES2561985T3 (es) 2001-10-10 2016-03-01 Ratiopharm Gmbh Remodelación y glicoconjugación de anticuerpos
CN1897812B (zh) * 2003-12-03 2011-08-17 生物种属学股份公司 糖聚乙二醇化的粒细胞集落刺激因子
WO2005121332A2 (en) 2004-06-03 2005-12-22 Neose Technologies, Inc. Truncated st6galnaci polypeptides and nucleic acids
KR20080021590A (ko) 2005-03-24 2008-03-07 네오스 테크놀로지스, 인크. 가용성이고 활성인 진핵생물 글리코실트랜스퍼라제의원핵생물 유기체 내에서의 발현
US20060246544A1 (en) 2005-03-30 2006-11-02 Neose Technologies,Inc. Manufacturing process for the production of peptides grown in insect cell lines
WO2007056524A2 (en) 2005-11-09 2007-05-18 Neose Technologies, Inc. St3gal-1/st6galnac-1 chimeras
JP2010505874A (ja) * 2006-10-03 2010-02-25 ノヴォ ノルディスク アー/エス ポリペプチドコンジュゲートの精製方法
US20080207487A1 (en) 2006-11-02 2008-08-28 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines

Also Published As

Publication number Publication date
WO2012016984A1 (en) 2012-02-09
CA2807397A1 (en) 2012-02-09
US20140057316A1 (en) 2014-02-27
EP2415779A1 (en) 2012-02-08
EP2415779B1 (en) 2015-01-21
CN103154017A (zh) 2013-06-12
PT2415779E (pt) 2015-05-13
ES2534936T3 (es) 2015-04-30
US9222081B2 (en) 2015-12-29
EP2601207A1 (en) 2013-06-12
JP5984267B2 (ja) 2016-09-06
EP2601207B1 (en) 2016-12-28
CN103154017B (zh) 2016-02-03
CA2807397C (en) 2019-03-19
JP2013535207A (ja) 2013-09-12

Similar Documents

Publication Publication Date Title
MX2013001447A (es) Metodo de produccion y purificacion de una sialiltransferasa soluble activa.
NZ705827A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
SG178925A1 (en) Process for producing molecules containing specialized glycan structures
WO2014028453A3 (en) Natural killer cells and uses thereof
PH12013500820B1 (en) Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
SG10201805291TA (en) Production of heterodimeric proteins
WO2013152051A3 (en) Improved production of fatty acid derivatives
MX2013004353A (es) Produccion recombinante de n-propanol e isopropanol.
MY198086A (en) Method for producing substituted 5-fluoro-1h-pyrazolopyridines
UA107678C2 (uk) Процес очищення рекомбінантного людського еритропоетину (епо), епо, очищений таким чином, та фармацевтична композиція, що містить його
MY171544A (en) A cell with reduced ppgppase activity
BR112013001179A2 (pt) sacrificação e fermentação em ph neutro.
NZ742660A (en) Variants of chymosin with improved milk-clotting properties
PH12012501438A1 (en) Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
PH12014502004A1 (en) An improved process for preparation of physiologically active polypeptide complex
EP2452931A4 (en) PROCESS FOR THE PREPARATION OF TRICYCLIC DERIVATIVES
IN2014CN03077A (enExample)
BR112014014762A8 (pt) método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase
PH12013500378A1 (en) Novel succinic acid-producing mutant microorganism that utilizes sucrose and glycerol simultaneously and method for producing succinic acid using the same
MX2010005015A (es) Metodos para preparar capecitabina y un compuesto de carbonato trialquilo rico en beta-anomero.
MY155284A (en) Process for the preparation of ajoene
MX2007010141A (es) Procesos para la preparacion de intermedios de linezolid.
EA201301294A1 (ru) Получение высокочистых мультисубъединичных белков, таких как антитела, в трансформированных микроорганизмах, например pichia pastoris
WO2011107843A3 (en) Process for the preparation of atazanavir sulfate substantially free of diastereomers
MX2015001413A (es) Metodo de alta eficiencia para purificar particulas similares a virus del virus del papiloma humano.